Which features predict mean survival of 18-24 months or longer for myelodysplastic syndrome (MDS)?

Updated: Jul 24, 2018
  • Author: Emmanuel C Besa, MD; Chief Editor: Koyamangalath Krishnan, MD, FRCP, FACP  more...
  • Print

Mean survival is 18-24 months or longer in patients with the following features:

  • Single or mild cytopenias

  • Normal chromosomes or a single chromosomal abnormality (except those involving chromosome 7)

  • Fewer than 10% myeloblasts in the bone marrow

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!